CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients | MicrobiomeTrials← Back to trialsNCT05726526
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-06-30Est. Completion: 2027-03-30
Enrollment target: 340 participants Locations- St. Boniface Hospital, Winnipeg, Manitoba, Canada
- Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Manitoba, Canada
- Health Sciences Centre, Winnipeg, Manitoba, Canada
- London Health Sciences Centre, London, Ontario, Canada
- Scarborough Health Network - General Hospital, Scarborough Village, Ontario, Canada
Other microbiome trials you might be interested in
CSA-AKIAcute Kidney InjuryCardiovascular Surgery
Cardiac surgery-associated Acute Kidney Injury (CSA-AKI) is one of the most common complications after cardiovascular Su…
Multiple LocationsEst. completion Dec 31, 2025
Hemodialysis
The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and …
Copenhagen, DenmarkEst. completion Oct 2028